13F filerCIK 1061768 ↗
Baupost Group
You are looking at Q4 2022. See the latest, Q3 2026 →
Reported value
$6.13B
+5.8% on the quarter before
Positions
34
5 new, 16 sold out
Top 10
71.5%
of the value
Est. gain
+$452.1M
on stocks held all quarter
Est. return
+8.9%
on those stocks since Q3 2022
Positions as of Dec 31, 2022, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2022. Striped tiles are options.
Largest buys
Since Q3 2022, sized at quarter-end prices.
- Alphabet~$232.3MAdded, 2.3% → 5.8% of the portfolio+2,618,000 shares
- Meta~$125.0MAdded, 1.6% → 3.4% of the portfolio+1,039,000 shares
- Fidelity Natl Information Sv~$104.5MAdded, 0.8% → 2.4% of the portfolio+1,540,000 shares
- Amazon~$62.3MAdded, 0.5% → 1.4% of the portfolio+742,000 shares
- Herbalife Nutrition Ltd~$29.8MNew, 0.0% → 0.5% of the portfolio+2,000,000 shares
- Warner Bros Discovery Inc~$19.0MAdded, 5.8% → 4.8% of the portfolio+2,000,000 shares
- Altice Usa Inc~$17.8MNew, 0.0% → 0.3% of the portfolio+3,880,200 shares
- Coinbase~$14.0MNew, 0.0% → 0.2% of the portfolio+25,250,000 shares
- Redfin Corp~$5.0MNew, 0.0% → 0.1% of the portfolio+8,480,000 shares
- Gray Television Inc~$2.8MAdded, 0.8% → 0.6% of the portfolio+250,000 shares
Largest sells
Since Q3 2022, sized at quarter-end prices.
- Dropbox Inc~$162.0MSold out, 2.8% → 0.0% of the portfolio−7,819,924 shares
- Fiserv Inc~$154.6MCut, 5.7% → 3.3% of the portfolio−1,530,000 shares
- Encompass Health Corp~$133.4MSold out, 2.3% → 0.0% of the portfolio−2,950,000 shares
- Qorvo~$94.7MCut, 9.3% → 8.5% of the portfolio−1,044,259 shares
- New Oriental Ed & Technology~$65.9MCut, 3.2% → 3.3% of the portfolio−1,891,778 shares
- Archaea Energy Inc~$51.2MSold out, 0.9% → 0.0% of the portfolio−2,930,297 shares
- Liberty Media Acquisition Co~$31.4MSold out, 0.5% → 0.0% of the portfolio−3,156,598 shares
- Theravance Biopharma Inc~$22.4MCut, 2.3% → 2.1% of the portfolio−2,000,000 shares
- Veritiv Corp~$13.7MCut, 5.8% → 6.6% of the portfolio−112,336 shares
- Nuvation Bio Inc~$10.8MCut, 0.4% → 0.2% of the portfolio−5,610,000 shares
Holdings
As of Dec 31, 2022; changes in shares since Sep 30, 2022.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Liberty Global PlcSHS CL C · shares −0.7% · price +17.8% | 15.1% | $923.0M | +$139.2M | ||||||
| Liberty Media Corp DelCOM C SIRIUSXM · shares −0.9% · price +3.8% | 8.7% | $534.2M | +$19.4M | ||||||
| QorvoCOM · shares −15% · price +14.1% | 8.5% | $519.5M | +$64.4M | ||||||
| Viasat IncCOM · shares 0% · price +4.7% | 8.4% | $515.5M | +$23.1M | ||||||
| Veritiv CorpCOM · shares −3.3% · price +24.5% | 6.6% | $404.6M | +$79.6M | ||||||
| AlphabetCAP STK CL C · shares +190% · price −7.7% | 5.8% | $354.4M | −$10.2M | ||||||
| Willis Towers Watson Plc LtdSHS · shares −0.4% · price +21.7% | 5.1% | $313.3M | +$55.9M | ||||||
| Liberty Media Corp DelCOM A SIRIUSXM · shares 0% · price +3.3% | 4.9% | $301.8M | +$9.5M | ||||||
| Warner Bros Discovery IncCOM SER A · shares +6.9% · price −17.6% | 4.8% | $293.9M | −$58.6M | ||||||
| Garrett Motion IncPFD CONV SER A · shares 0% · price +22.4% | 3.6% | $221.7M | +$40.5M | ||||||
| MetaCL A · shares +151% · price −11.3% | 3.4% | $207.9M | −$10.6M | ||||||
| Fiserv IncCOM · shares −43% · price +8.0% | 3.3% | $202.4M | +$15.0M | ||||||
| New Oriental Ed & TechnologySPON ADR · shares −25% · price +45.3% | 3.3% | $201.7M | +$62.9M | ||||||
| Ss&C Technologies Hldgs IncCOM · shares 0% · price +9.0% | 3.2% | $196.4M | +$16.3M | ||||||
| MicronCOM · shares 0% · price −0.2% | 2.7% | $164.2M | −$394,000 | ||||||
| Fidelity Natl Information SvCOM · shares +250% · price −10.2% | 2.4% | $146.2M | −$4.7M | ||||||
| Liberty Global PlcSHS CL A · shares 0% · price +21.4% | 2.2% | $136.2M | +$24.0M | ||||||
| Theravance Biopharma IncCOM · shares −15% · price +10.7% | 2.1% | $128.1M | +$12.3M | ||||||
| AmazonCOM · shares +299% · price −25.7% | 1.4% | $83.2M | −$7.2M | ||||||
| Lithia Mtrs IncCOM · shares 0% · price −4.6% | 0.83% | $51.2M | −$2.5M | ||||||
| Gray Television IncCOM · shares +7.7% · price −21.9% | 0.64% | $39.3M | −$10.2M | ||||||
| Digitalbridge Group IncCL A NEW · shares −2.7% · price −12.5% | 0.57% | $35.0M | −$5.0M | ||||||
| Herbalife Nutrition LtdCOM SHS · shares New | 0.49% | $29.8M | — | ||||||
| Garrett Motion IncCOM · shares 0% · price +34.9% | 0.44% | $27.2M | +$7.0M | ||||||
| Atara Biotherapeutics IncCOM · shares 0% · price −13.2% | 0.43% | $26.6M | −$4.1M | ||||||
| Total 34 positions | 100% | $6.13B | +$452.1M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2022 to Q4 2022: 29 stocks held throughout, up $452.1M (+8.9%).
- Liberty Global Plc+$139.2M+18%
- Veritiv Corp+$79.6M+24%
- Qorvo+$64.4M+14%
- New Oriental Ed & Technology+$62.9M+45%
- Willis Towers Watson Plc Ltd+$55.9M+22%
- Amazon−$7.2M−26%
- Gray Television Inc−$10.2M−22%
- Alphabet−$10.2M−8%
- Meta−$10.6M−11%
- Warner Bros Discovery Inc−$58.6M−18%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 13, 2026 | $5.05B−7% | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | $5.42B+6% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $5.12B−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $5.28B+10% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $4.79B+16% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $4.13B+18% | SEC ↗ |
| Q1 2025 | May 14, 2025 | $3.50B+2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $3.43B−2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $3.52B−3% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.63B−0% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $3.65B−20% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $4.59B−12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $5.21B−7% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $5.61B−4% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $5.85B−5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $6.13B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.79B−14% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $6.77B−27% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $9.30B−8% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $10.13B−7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $10.88B−12% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $12.33B−2% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $12.56B+16% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $10.84B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $9.25B+15% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $8.01B+18% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $6.77B−25% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $9.06B+3% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $8.83B−20% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $11.05B−7% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $11.90B+3% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $11.52B−12% | SEC ↗ |
| Q3 2018 | Nov 15, 2018 (amended) | $13.06B+14% | SEC ↗ |
| Q2 2018 | Aug 13, 2018 | $11.44B+10% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $10.37B+3% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $10.11B+26% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $8.02B−8% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $8.75B+3% | SEC ↗ |
| Q1 2017 | May 25, 2017 (amended) | $8.49B+11% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $7.67B+9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $7.04B−4% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $7.37B+6% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $6.92B | SEC ↗ |